OpenAI acquires Orchestra Bio for drug development
OpenAI has acquired Orchestra Bio, a San Francisco-based startup founded in 2022 that builds AI agents for pharmaceutical development programs. Orchestra's staf...
AI BIOTECH ACQUISITION
3 articles
OpenAI Acquires Orchestra Bio for Biotech Push
OpenAI has acquired Orchestra Bio, a four-year-old AI biotech startup that raised around $20 million from backers including Andreessen Horowitz, Atria, and 8VC....
Anthropic Acquires Biotech Startup for $400M
Anthropic has acquired Coefficient Bio, a stealth New York biotech AI startup, in a stock deal valued at over $400 million. The small team of fewer than 10 peop...